Inflammation in Cardiovascular Tissue Engineering: The Challenge to a Promise: A Minireview

Tissue engineering employs scaffolds, cells, and stimuli brought together in such a way as to mimic the functional architecture of the target tissue or organ. Exhilarating advances in tissue engineering and regenerative medicine allow us to envision in vitro creation or in vivo regeneration of cardi...

Full description

Saved in:
Bibliographic Details
Main Authors: Agneta Simionescu, Jason B. Schulte, George Fercana, Dan T. Simionescu
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Inflammation
Online Access:http://dx.doi.org/10.4061/2011/958247
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850120681654583296
author Agneta Simionescu
Jason B. Schulte
George Fercana
Dan T. Simionescu
author_facet Agneta Simionescu
Jason B. Schulte
George Fercana
Dan T. Simionescu
author_sort Agneta Simionescu
collection DOAJ
description Tissue engineering employs scaffolds, cells, and stimuli brought together in such a way as to mimic the functional architecture of the target tissue or organ. Exhilarating advances in tissue engineering and regenerative medicine allow us to envision in vitro creation or in vivo regeneration of cardiovascular tissues. Such accomplishments have the potential to revolutionize medicine and greatly improve our standard of life. However, enthusiasm has been hampered in recent years because of abnormal reactions at the implant-host interface, including cell proliferation, fibrosis, calcification and degeneration, as compared to the highly desired healing and remodeling. Animal and clinical studies have highlighted uncontrolled chronic inflammation as the main cause of these processes. In this minireview, we present three case studies highlighting the importance of inflammation in tissue engineering heart valves, vascular grafts, and myocardium and propose to focus on the endothelial barrier, the “final frontier” endowed with the natural potential and ability to regulate inflammatory signals.
format Article
id doaj-art-60adebb7474844aeb98404614c3c296f
institution OA Journals
issn 2042-0099
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Inflammation
spelling doaj-art-60adebb7474844aeb98404614c3c296f2025-08-20T02:35:18ZengWileyInternational Journal of Inflammation2042-00992011-01-01201110.4061/2011/958247958247Inflammation in Cardiovascular Tissue Engineering: The Challenge to a Promise: A MinireviewAgneta Simionescu0Jason B. Schulte1George Fercana2Dan T. Simionescu3Biocompatibility and Tissue Regeneration Laboratory, Department of Bioengineering, Clemson University, 304 Rhodes Center, Clemson, SC 29634, USABiocompatibility and Tissue Regeneration Laboratory, Department of Bioengineering, Clemson University, 304 Rhodes Center, Clemson, SC 29634, USABiocompatibility and Tissue Regeneration Laboratory, Department of Bioengineering, Clemson University, 304 Rhodes Center, Clemson, SC 29634, USABiocompatibility and Tissue Regeneration Laboratory, Department of Bioengineering, Clemson University, 304 Rhodes Center, Clemson, SC 29634, USATissue engineering employs scaffolds, cells, and stimuli brought together in such a way as to mimic the functional architecture of the target tissue or organ. Exhilarating advances in tissue engineering and regenerative medicine allow us to envision in vitro creation or in vivo regeneration of cardiovascular tissues. Such accomplishments have the potential to revolutionize medicine and greatly improve our standard of life. However, enthusiasm has been hampered in recent years because of abnormal reactions at the implant-host interface, including cell proliferation, fibrosis, calcification and degeneration, as compared to the highly desired healing and remodeling. Animal and clinical studies have highlighted uncontrolled chronic inflammation as the main cause of these processes. In this minireview, we present three case studies highlighting the importance of inflammation in tissue engineering heart valves, vascular grafts, and myocardium and propose to focus on the endothelial barrier, the “final frontier” endowed with the natural potential and ability to regulate inflammatory signals.http://dx.doi.org/10.4061/2011/958247
spellingShingle Agneta Simionescu
Jason B. Schulte
George Fercana
Dan T. Simionescu
Inflammation in Cardiovascular Tissue Engineering: The Challenge to a Promise: A Minireview
International Journal of Inflammation
title Inflammation in Cardiovascular Tissue Engineering: The Challenge to a Promise: A Minireview
title_full Inflammation in Cardiovascular Tissue Engineering: The Challenge to a Promise: A Minireview
title_fullStr Inflammation in Cardiovascular Tissue Engineering: The Challenge to a Promise: A Minireview
title_full_unstemmed Inflammation in Cardiovascular Tissue Engineering: The Challenge to a Promise: A Minireview
title_short Inflammation in Cardiovascular Tissue Engineering: The Challenge to a Promise: A Minireview
title_sort inflammation in cardiovascular tissue engineering the challenge to a promise a minireview
url http://dx.doi.org/10.4061/2011/958247
work_keys_str_mv AT agnetasimionescu inflammationincardiovasculartissueengineeringthechallengetoapromiseaminireview
AT jasonbschulte inflammationincardiovasculartissueengineeringthechallengetoapromiseaminireview
AT georgefercana inflammationincardiovasculartissueengineeringthechallengetoapromiseaminireview
AT dantsimionescu inflammationincardiovasculartissueengineeringthechallengetoapromiseaminireview